Cargando…

Paradoxical immune response in leishmaniasis: The role of toll‐like receptors in disease progression

Toll‐like receptors (TLRs), members of pattern recognition receptors, are expressed on many cells of the innate immune system, and their engagements with antigens regulate specific immune responses. TLRs signalling influences species‐specific immune responses during Leishmania infection; thus, TLRs...

Descripción completa

Detalles Bibliográficos
Autores principales: Bamigbola, Ifeoluwa E., Ali, Selman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285711/
https://www.ncbi.nlm.nih.gov/pubmed/35119120
http://dx.doi.org/10.1111/pim.12910
_version_ 1784747842711060480
author Bamigbola, Ifeoluwa E.
Ali, Selman
author_facet Bamigbola, Ifeoluwa E.
Ali, Selman
author_sort Bamigbola, Ifeoluwa E.
collection PubMed
description Toll‐like receptors (TLRs), members of pattern recognition receptors, are expressed on many cells of the innate immune system, and their engagements with antigens regulate specific immune responses. TLRs signalling influences species‐specific immune responses during Leishmania infection; thus, TLRs play a decisive role towards elimination or exacerbation of Leishmania infection. To date, there is no single therapeutic or prophylactic approach that is fully effective against leishmaniasis. An in‐depth understanding of the mechanisms by which Leishmania species evade, or exploit host immune machinery could lead to the development of novel therapeutic approaches for the prevention and management of leishmaniasis. In this review, the role of TLRs in the induction of a paradoxical immune response in leishmaniasis was discussed. This review focuses on highlighting the novel interplay of TLR2‐ /TLR9‐driven resistance or susceptibility to 5 clinically important Leishmania species in human. The activation of TLR2/TLR9 can induce diverse anti‐Leishmania activities depending on the species of infecting Leishmania parasite. Infection with L. infantum and L. mexicana initiates TLR2/9 activation leading to host protective immune response, while infection with L. major, L. donovani and L. amazonensis trigger either a TLR2‐ /9‐related protective or non‐protective immune responses. These findings suggest that TLR2 and TLR9 are targets worth pursuing either for modulation or blockage to trigger host protective immune response towards leishmaniasis.
format Online
Article
Text
id pubmed-9285711
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92857112022-07-18 Paradoxical immune response in leishmaniasis: The role of toll‐like receptors in disease progression Bamigbola, Ifeoluwa E. Ali, Selman Parasite Immunol Review Article Toll‐like receptors (TLRs), members of pattern recognition receptors, are expressed on many cells of the innate immune system, and their engagements with antigens regulate specific immune responses. TLRs signalling influences species‐specific immune responses during Leishmania infection; thus, TLRs play a decisive role towards elimination or exacerbation of Leishmania infection. To date, there is no single therapeutic or prophylactic approach that is fully effective against leishmaniasis. An in‐depth understanding of the mechanisms by which Leishmania species evade, or exploit host immune machinery could lead to the development of novel therapeutic approaches for the prevention and management of leishmaniasis. In this review, the role of TLRs in the induction of a paradoxical immune response in leishmaniasis was discussed. This review focuses on highlighting the novel interplay of TLR2‐ /TLR9‐driven resistance or susceptibility to 5 clinically important Leishmania species in human. The activation of TLR2/TLR9 can induce diverse anti‐Leishmania activities depending on the species of infecting Leishmania parasite. Infection with L. infantum and L. mexicana initiates TLR2/9 activation leading to host protective immune response, while infection with L. major, L. donovani and L. amazonensis trigger either a TLR2‐ /9‐related protective or non‐protective immune responses. These findings suggest that TLR2 and TLR9 are targets worth pursuing either for modulation or blockage to trigger host protective immune response towards leishmaniasis. John Wiley and Sons Inc. 2022-02-28 2022 /pmc/articles/PMC9285711/ /pubmed/35119120 http://dx.doi.org/10.1111/pim.12910 Text en © 2022 The Authors. Parasite Immunology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Bamigbola, Ifeoluwa E.
Ali, Selman
Paradoxical immune response in leishmaniasis: The role of toll‐like receptors in disease progression
title Paradoxical immune response in leishmaniasis: The role of toll‐like receptors in disease progression
title_full Paradoxical immune response in leishmaniasis: The role of toll‐like receptors in disease progression
title_fullStr Paradoxical immune response in leishmaniasis: The role of toll‐like receptors in disease progression
title_full_unstemmed Paradoxical immune response in leishmaniasis: The role of toll‐like receptors in disease progression
title_short Paradoxical immune response in leishmaniasis: The role of toll‐like receptors in disease progression
title_sort paradoxical immune response in leishmaniasis: the role of toll‐like receptors in disease progression
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285711/
https://www.ncbi.nlm.nih.gov/pubmed/35119120
http://dx.doi.org/10.1111/pim.12910
work_keys_str_mv AT bamigbolaifeoluwae paradoxicalimmuneresponseinleishmaniasistheroleoftolllikereceptorsindiseaseprogression
AT aliselman paradoxicalimmuneresponseinleishmaniasistheroleoftolllikereceptorsindiseaseprogression